NOORSABA BAHRAMZI: Open Payments
NPI 1992270698 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 8 payments from 7 companies in 2025. Trend: 2023 $241 · 2024 $427 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $291 |
| Alkermes, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $106 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Lundbeck LLC | 1 | $31 |
| LivaNova USA, Inc. | 1 | $29 |
Products named: INVEGA SUSTENNA, LYBALVI, AUSTEDO XR, Auvelity, INGREZZA, REXULTI, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR.
Industry payments across CA — which companies pay providers there.
